To evaluate the diagnostic value of macroscopic haematuria for the diagnosis of urological cancers in primary care, as well as referred patients.
To evaluate the diagnostic value of macroscopic haematuria for the diagnosis of urological cancers in primary care, as well as referred patients.
Searching
MEDLINE was searched from 1966 to 1995 using MeSH terms and free text (the keywords were provided); FAMLI was searched from 1980 to 1991. In addition, a number of general practice journals that were published in Dutch and not indexed in MEDLINE were searched manually, and the reference lists of all selected papers were examined.
Study selection

Study designs of evaluations included in the review
No inclusion criteria were specified with respect to the study design. The included studies were prospective or retrospective diagnostic cohorts.
Specific interventions included in the review
Studies evaluating visual observation of gross/macroscopic haematuria were eligible for inclusion. For the estimation of sensitivity, only studies presenting information on the presence or absence of gross haematuria for all patients were eligible for inclusion. For the estimation of positive predictive value (PPV), studies in which some or all of the patients presented with self-reported gross haematuria were included.
Reference standard test against which the new test was compared
No inclusion criteria were specified with respect to the reference standard test. The detection of urological cancers was used as the reference standard for estimating the PPV, but the methods of detection used in the individual studies were not reported. For the estimation of sensitivity, primary studies included only patients with known urological cancers.
Participants included in the review
For the estimation of PPV, studies of ambulatory patients complaining to their physicians of gross haematuria were eligible for inclusion. For the estimation of sensitivity, studies of patients with proven cancer of the kidney, ureter, bladder, urethra or prostate were eligible for inclusion.
Outcomes assessed in the review
No inclusion criteria were specified with respect to the outcome measures. The outcome measures used in the review were the sensitivity and PPV of macroscopic haematuria. Where these data were not presented in the primary studies, they were calculated.
How were decisions on the relevance of primary studies made?
The authors do not state how the papers were selected for the review, or how many of the reviewers performed the selection.
Assessment of study quality
The methodological quality was gauged through the systematic scoring of five quality indicators: type of data collection, setting, number of patients in the study, age distribution and gender ratio. An estimate of indication bias for PPV studies was given by listing the other diagnostic investigations performed systematically. The authors do not state how the papers were assessed for quality, or how many of the reviewers performed the quality assessment.
